Glimepiride is a third-generation sulfonylurea that helps lower blood sugar by increasing insulin release from pancreatic beta cells. It is known for its once-daily dosing and relatively lower risk of hypoglycemia compared to older sulfonylureas. Glimepiride is often used as a first-line or add-on therapy in type 2 diabetes.